Kite Pharma, Inc. 4
4 · Kite Pharma, Inc. · Filed May 10, 2017
Insider Transaction Report
Form 4
Ruchefsky Steven B
Director
Transactions
- Purchase
Common Stock
2017-05-09$69.50/sh+1,400$97,300→ 225,426 total
Footnotes (1)
- [F1]Includes 136,038 shares, previously registered in the name of Commercial Street Capital, LLC, which were distributed to the Reporting Person on April 3, 2017 in a pro rata distribution and are now owned directly.